Delivery Order SPE2DB20D2104-SPE2DB25FNBQG
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,448.30 to AmerisourceBergen Drug Corp for supply of REXULTI 0.5 mg tablets (30-count packages). This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of REXULTI 1 mg tablets (30-count units) with a ceiling value of $10,390.65. This firm fixed-price delivery order, which is expected to complete by July 29, 2025, represents a non-set-aside competitive award and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. REXULTI is a prescription antipsychotic medication used to treat major depressive disorder and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,179.29 to AmerisourceBergen Drug Corp for the supply of REXULTI 3 mg tablets (30-count packages) with an ultimate completion date of July 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was issued on July 7, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $23,464.63 to AmerisourceBergen Drug Corp for REXULTI 2 mg tablets (30-count supply) with an ultimate completion date of July 1, 2025. This firm fixed-price, non-set-aside contract represents a single delivery under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This...
- On June 18, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for REXULTI (brexpiprazole) 0.5 mg tablets in a 30-count package. This is a firm fixed price delivery order with a ceiling value of $6,777.17 and a completion date of June 20, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,259.26 for REXULTI 0.5 mg tablets (30-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded contract (no set-aside designation) leverages AmerisourceBergen's position as a prime vendor under the DLA Troop Support Medical Indefinite Delivery Contract SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $10,248.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for REXULTI 1 mg tablets (30-count packages) with an ultimate completion date of July 24, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a $33,475.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REXULTI 2 mg tablets (30-count supply) with an ultimate completion date of September 15, 2025. This non-set-aside contract was competitively awarded and represents a direct procurement of pharmaceutical inventory to support federal medical supply needs. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $2,012.54 to AmerisourceBergen Drug Corp for the supply of REXULTI (brexpiprazole) 1 mg tablets in a 30-count package. This competitively awarded, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $19,710.72 to AmerisourceBergen Drug Corp for the supply of REXULTI 0.5 mg tablets in a 30-count package. The contract was competitively awarded without set-aside designation on May 27, 2025, with a completion date of May 28, 2025. This delivery order operates under a firm fixed-price arrangement and represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...